[HTML][HTML] The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and …
W Wu, Y Cheng, H Zhou, C Sun, S Zhang - Virology journal, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) continues to take a heavy toll on personal
health, healthcare systems, and economies around the globe. Scientists are expending …
health, healthcare systems, and economies around the globe. Scientists are expending …
[HTML][HTML] The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems
Background: Post-acute sequelae of SARS-CoV-2 infection (PASC) is a complicated
disease that affects millions of people all over the world. Previous studies have shown that …
disease that affects millions of people all over the world. Previous studies have shown that …
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
A Hromić-Jahjefendić, K Lundstrom, M Adilović… - Autoimmunity …, 2023 - Elsevier
The complicated relationships between autoimmunity, COVID-19, and COVID-19
vaccinations are described, giving insight into their intricacies. Antinuclear antibodies (ANA) …
vaccinations are described, giving insight into their intricacies. Antinuclear antibodies (ANA) …
ACVPred: Enhanced prediction of anti-coronavirus peptides by transfer learning combined with data augmentation
Anti-coronavirus peptides (ACVPs) have garnered significant attention in COVID-19
therapeutic research due to their precise targeting, low risk of drug resistance, flexible …
therapeutic research due to their precise targeting, low risk of drug resistance, flexible …
[HTML][HTML] Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Y Matsuzaka, R Yashiro - Vaccines, 2023 - mdpi.com
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines.
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Antiviral Flavonoids: A Natural Scaffold with Prospects as Phytomedicines against SARS-CoV2
C Saha, R Naskar, S Chakraborty - Mini Reviews in Medicinal …, 2024 - ingentaconnect.com
Flavonoids are vital candidates to fight against a wide range of pathogenic microbial
infections. Due to their therapeutic potential, many flavonoids from the herbs of traditional …
infections. Due to their therapeutic potential, many flavonoids from the herbs of traditional …
SARS-CoV-2 Variants and Global Vulnerability: Diagnostic, Vaccines, and Therapeutic Management
RM Bashatwah, AAA Aljabali… - SARS-CoV-2 Variants …, 2024 - taylorfrancis.com
SARS-CoV-2 is an emerging variant responsible for the causes a severe pandemic, and that
leads to various complications in the people, including severe respiratory symptoms, and …
leads to various complications in the people, including severe respiratory symptoms, and …
Antibody fragment VH ab6: universal neutralizer for SARS-CoV-2 variants
MI Mustafa, AM Makhawi - Journal of Bio-X Research, 2023 - mednexus.org
The recent coronavirus disease 2019 (COVID-19) outbreak has highlighted the inadequacy
of our ability to respond to newly emerging viruses. Antiviral medications are the most …
of our ability to respond to newly emerging viruses. Antiviral medications are the most …